A CRA expert provided an opinion on damages in patent litigation concerning intellectual property used in a vaccine for porcine viruses. CRA’s reasonable royalty opinion, on behalf of the defendant animal health company, was based in large part upon the payment terms of an existing license previously granted by the plaintiff.
Trade Secret Litigation Watch: February 2026
In this second installment of the Trade Secret Litigation Watch, CRA’s Intellectual Property team examines emerging trends and case outcomes with an emphasis...